FOLLOW US

  • facebook
  • twitter
Tue

March 24, 2026

Slate Medicines Raises $130 Million Series A

America February 24, 2026

Slate Medicines Raises $130 Million Series A to Advance Anti-PACAP Monoclonal Antibody for Migraine Prevention

Slate Medicines Inc., a Raleigh, North Carolina-based biotechnology company focused on next-generation treatments for headache disorders, announced Tuesday it has…

By Rachel Moore

Tola Capital Closes $230M Funding Round

America November 29, 2023

Tola Capital Closes $230M Funding Round

In the bustling tech hub of Seattle, Tola Capital, a prominent venture capital firm, announced a striking achievement on Wednesday.…

By Rihem Akkouche

Signup for the USA Herald
exclusive Newsletter